Perioperative plasma glypican-3 level may enable prediction of the risk of recurrence after surgery in patients with stage I hepatocellular carcinoma-Reference-Cited by-同舟云学术

Perioperative plasma glypican-3 level may enable prediction of the risk of recurrence after surgery in patients with stage I hepatocellular carcinoma

Published:2016-12-27 Issue:23 Volume:8 Page:37835-37844
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Ofuji Kazuya¹²,Saito Keigo¹,Suzuki Shiro¹,Shimomura Manami¹,Shirakawa Hirofumi¹,Nobuoka Daisuke¹,Sawada Yu¹,Yoshimura Mayuko¹,Tsuchiya Nobuhiro¹,Takahashi Mari¹,Yoshikawa Toshiaki¹,Tada Yoshitaka¹,Konishi Masaru³,Takahashi Shinichiro³,Gotohda Naoto³,Nakamoto Yasunari²,Nakatsura Tetsuya¹

Affiliation:

1. Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Chiba 277-8577, Japan

2. Second Department of Internal Medicine, University of Fukui, Eiheiji-cho Yoshida-gun, Fukui 910-1193, Japan

3. Division of Hepatobiliary Pancreatic Surgery, National Cancer Center Hospital East, Kashiwa, Chiba 277-8577, Japan

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum glypican-3 for the prediction of survival in patients with hepatocellular carcinoma;Minerva Gastroenterology;2022-12

2. Production and characterization of GPC3-N protein and its nanobody;Protein Expression and Purification;2022-08

3. Circulating Proteoglycans/Glycosaminoglycans as Cancer Biomarkers;The Extracellular Matrix and the Tumor Microenvironment;2022

4. Screening of MicroRNA Related to Irradiation Response and the Regulation Mechanism of miRNA-96-5p in Rectal Cancer Cells;Frontiers in Oncology;2021-08-11

5. Mechanisms and Clinical Trials of Hepatocellular Carcinoma Immunotherapy;Frontiers in Genetics;2021-07-08